Senzar Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Senzar Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-453,392	Closed	-$11M	–	49
2015 Q2	$11M	Buy	453,392 +35,700	+9%	+$855K	1.89%	22
2015 Q1	$9.71M	Buy	417,692 +149,392	+56%	+$3.95M	2.37%	17
2014 Q4	$6.74M	Buy	268,300 +113,400	+73%	+$3.33M	1.97%	24
2014 Q3	$4.82M	Sell	154,900 -28,200	-15%	-$764K	1.41%	20
2014 Q2	$4.74M	Buy	183,100 +47,700	+35%	+$1.06M	1.81%	20
2014 Q1	$3.16M	Buy	+135,400	New	+$2.96M	1.68%	16

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Senzar Asset Management's SGNT Position: Q3 2015 in Review

Senzar Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 453,392 shares — an estimated $11M sold.

Senzar Asset Management first reported a position in SGNT in Q1 2014 and held it in 6 quarters. The position peaked at $11M in Q2 2015. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

Senzar Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Senzar Asset Management sold 453,392 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $11M.
Senzar Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 6 quarters.
Senzar Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $11M in Q2 2015.
127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Senzar Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.